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ABSTRACT: Natural products and synthetic compounds are a valuable source
of new small molecules leading to novel drugs to cure diseases. However
identifying new biologically active small molecules is still a challenge. In this
paper, we introduce a new activity prediction approach using Bayesian belief
network for classiﬁcation (BBNC). The roots of the network are the fragments
composing a compound. The leaves are, on one side, the activities to predict and,
on another side, the unknown compound. The activities are represented by sets of
known compounds, and sets of inactive compounds are also used. We calculated a
similarity between an unknown compound and each activity class. The more
similar activity is assigned to the unknown compound. We applied this new
approach on eight well-known data sets extracted from the literature and
compared its performance to three classical machine learning algorithms. Experiments showed that BBNC provides interesting
prediction rates (from 79% accuracy for high diverse data sets to 99% for low diverse ones) with a short time calculation.
Experiments also showed that BBNC is particularly eﬀective for homogeneous data sets but has been found to perform less well
with structurally heterogeneous sets. However, it is important to stress that we believe that using several approaches whenever
possible for activity prediction can often give a broader understanding of the data than using only one approach alone. Thus,
BBNC is a useful addition to the computational chemist’s toolbox.
■ INTRODUCTION
Due to the similar property principle,1 structurally similar
compounds are expected to exhibit similar properties and
similar biological activities. This principle is exploited for in
silico discovery of new drugs with the emergence of an activity
prediction technology based on chemical structures. A variety
of computational approaches for target or activity prediction
were published over the past several years. For example,
quantitative structure−activity relationship (QSAR)2−5 was
established on the hypothesis that compounds with similar
physicochemical properties and/or structure share similar
activities. The eﬀectiveness of a QSAR analysis relies both on
selecting the relevant descriptors for modeling the biological
activity of interest and on the choice of a good quantitative
model that maps the compound descriptors to chemical
property or biological activity by means of statistical techniques.
In similarity searching strategies, an unknown compound (the
target) is compared to a set of compounds with known
activities. The activity for which the compounds are the most
similar to the target is assigned to it. Binary kernel
discrimination (BKD),6,7 naıv̈e Bayesian classiﬁer (NBC),8−11
artiﬁcial neural networks (ANN),12−16 and support vector
machine (SVM)17−19 are machine learning methods employed
for activity prediction by compound classiﬁcation. They can
only be applied when annotated compounds are available to
design a training set divided in an active class (compounds
having a speciﬁc activity) and an inactive one (compounds
belonging to other activities). The training set is then analyzed
to develop decision rules that classify new compounds (the test
set) into one of the two classes (active or inactive). The
learning step, needed to determine the criteria for the
classiﬁcation of an unknown compound is time-consuming
because many criteria are explored.
Overall, while target prediction approaches exhibit several
successes, some issues need to be addressed. In many studies,
diﬀerent approaches predict a diﬀerent subset of targets for the
same compound.20−22 Moreover, given that the approach might
work better on speciﬁc targets or databases in a way that is
diﬃcult to predict beforehand, should we ignore approaches
with low or similar performance? We think the answer is no
because it is hard to predict which approach will do better on a
given combination of database and query. Also, each approach
may be able to predict speciﬁc targets that all others could not.
It is important to stress that we believe that using several
approaches whenever possible for target prediction can often
give a broader understanding of the data than using only one
approach alone.6
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Previously, Abdo and Salim23 developed a ligand-based
virtual screening method that used a Bayesian inference
network (BIN) for similarity searching. Experiments with a
subset of the MDDR and WOMBAT24 databases demonstrated
that the BIN provided an interesting alternative to existing tools
for ligand-based virtual screening. It substantially outperformed
a conventional Tanimoto-based similarity searching system
when the active molecules have a high degree of structural
homogeneity. To overcome this limitation, an alternative
Bayesian network model called Bayesian belief network
(BBN) has been introduced by Abdo et al.25 In this paper,
we introduce a new activity prediction approach using Bayesian
belief network, but this time for classiﬁcation. We suggest that
the BBN model introduced by Abdo et al.25 for similarity
searching can be applied to classiﬁcation of small molecules in
activity classes. The purpose of this paper is to introduce BBN
model as a useful tool for activity prediction. We show that it
provides a useful method for using the prior knowledge of
target class information (active and inactive compounds) to
predict the activity of orphan compounds. We apply this new
approach on eight well-known data sets extracted from
literature and compare its performance with three classical
machine learning algorithms.
■ MATERIALS AND METHODS
Data Sets. We evaluate the quality of our prediction model
on eight data sets already used to validate the classiﬁcation of
molecules based on structure−activity relationship. The ﬁve
data sets described in Table 1 are taken from the studies of
Sutherland et al.26 and Helma et al.27 with compounds classiﬁed
as active or inactive: (1) 467 cyclooxygenase-2 (COX2)
inhibitors, (2) 405 ligands of the benzodiazepine receptor
(BZR), (3) 756 dihydrofolate reductase (DHFR) inhibitors,
(4) 393 ligands of the estrogen receptor (ER), and (5) 683
mutagens (MUT) of molecular structures. These data sets have
been used by many studies for validating prediction
models.2,28−30
The sixth data set (Table 2) of this study is taken from the
Norine database (version of August 2013), which contains 1122
peptides with 11 distinct activities.31 We have restricted our
data set to 605 peptides, belonging to ﬁve diﬀerent activity
classes.32 The last two data sets (Tables 3 and 4) are chosen
from the MDL Drug Data Report (MDDR)33 and have been
extensively used by many studies for validating ligand-based
virtual screening approaches.34−37 The data sets MDDR1 and
MDDR2 contain 10 homogeneous activity classes and 10
heterogeneous ones, respectively. Each row of data set tables
(Tables 2−4) contains an activity class, the number of
molecules/peptides belonging to the class, and the diversity
of classes, which is computed as the mean pairwise Tanimoto
similarity calculated across all pairs of molecules/peptides in
the class using ECFC4 (extended connectivity) for data sets in
Tables 1, 3, and 4 and monomer composition ﬁngerprints
(MCFP)32 in the Norine data set. For Norine and MDDR data
sets, each activity class is considered, one by one, as active set
and the others as the inactive set.
All compounds in the ﬁrst ﬁve data sets and MDDR data sets
are converted to Pipeline Pilot’s ECFC4 ﬁngerprints and folded
to a size of 1024.38 ECFC4 ﬁngerprints have been successfully
used by many previous studies. For the Norine data set, all the
peptides are converted to MCFP. MCFP is a novel
representation we have developed for obtaining an appropriate
description of nonribosomal peptides in relation to their
activity. So, the compounds of all data sets are represented by
ﬁngerprints containing the frequency of each fragment within it.
However, it should be noticed that it is not our intention to
tackle here the question of which is the most appropriate
ﬁngerprint/descriptor.
Table 1. Summary of the First Fifth Data Setsa
no. compounds
pairwise similarity
(mean)
data set active inactive active inactive
cyclooxygenase-2 inhibitors 303 164 0.687 0.690
benzodiazepine receptor 306 99 0.536 0.538
dihydrofolate reductase 393 363 0.502 0.537
estrogen receptor 141 252 0.468 0.456
mutagens 340 343 0.143 0.125
aEach row in Tables 1−3 contains an activity class, the number of
compounds belonging to the class, and the class’s diversity, which was
computed as the mean pairwise Tanimoto similarity calculated across
all pairs of molecules in the class using ECFC4.
Table 2. Summary of Norine Data Set
activity class NRPs number pairwise similarity (mean)
antibiotics 319 0.09
toxin 157 0.09
siderophore 82 0.18
antitumor 25 0.27
protease inhibitors 22 0.26
Table 3. MDDR Activity Classes for MDDR1 Data Set
activity
index activity class
active
molecules
pairwise similarity
(mean)
07707 adenosine (A1)
agonists
207 0.424
07708 adenosine (A2)
agonists
156 0.484
31420 renin inhibitors 1130 0.584
42710 monocyclic beta-
lactams
111 0.596
64100 cephalosporins 1346 0.512
64200 carbacephems 113 0.503
64220 carbapenems 1051 0.414
64300 penicillin 126 0.444
65000 antibiotic, macrolide 388 0.673
75755 vitamin D analogous 455 0.569
Table 4. MDDR Activity Classes for MDDR2 Data Set
activity
index activity class
active
molecules
pairwise similarity
(mean)
09249 muscarinic (M1) agonists 900 0.257
12455 NMDA receptor antagonists 1400 0.311
12464 nitric oxide synthase
inhibitors
505 0.237
31281 dopamine beta-hydroxylase
inhibitors
106 0.324
43210 aldose reductase inhibitors 957 0.370
71522 reverse transcriptase
inhibitors
700 0.311
75721 aromatase inhibitors 636 0.318
78331 cyclooxygenase inhibitors 636 0.382
78348 phospholipase A2 inhibitors 617 0.291
78351 lipoxygenase inhibitors 2111 0.365
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As classes contain a set of compounds, we calculated a
representative ﬁngerprint. For each bit of the ﬁngerprint
representing a given fragment f, we have taken the average
number of occurrences of f within a class c according to the
following formula:
= Σc
f c
av(nb ( ))
1
nb ( , )
nb (co)f
c
f
co
nb ( )co
(1)
where nbco( f, c) is the number of compounds containing the
fragment f within the class c and nbco(c) is the number of
compounds in the class c and nbf(co) is the number of
occurrences of the fragment f in the compound co.
Bayesian Belief Network Classiﬁer Model (BBNC). The
BBNC model is based on Bayesian belief network model (for
more details about BBN see ref 25) but adapted to activity
prediction (classiﬁcation rather than similarity searching).
The BBNC model, shown in Figure 1, consists of three types
of nodes. The roots are the fragment nodes f. Each node
represents a bit of the ﬁngerprints generated for the
compounds, i.e., the presence/absence of particular chemical
substructures. Both class and molecule nodes, the leaves, are
described using a set of fragment nodes. The class nodes c
represents the compound collections for the diﬀerent biological
activities that are part of the training set, summarized by the
average frequency of formula 1. The ﬁrst ﬁve data sets contain 2
class nodes, 5 class nodes for Norine, and 10 for MDDR1 and
MDDR2. The other type of leaf is the molecule node t
representing the molecule for which we want to predict an
activity (unknown natural compound or target of an unknown
protein). For simplicity of processing, the fragment occurrences
are assumed to be statistically independent of each other, an
assumption that was also adopted in our previous BIN and
BBN works. An edge is traced from one fragment node to one
class or molecule node if the fragment appears in that class/
molecule.
To build a robust model that distinguish eﬃciently the
classes and then give the right prediction, we excluded the very
rare and predominant fragments that introduce noise in the
data. We determined empirically the rare fragments as the ones
covering less than 3% of the active molecules in the training set
and the predominant ones covering more than 50% of the
active set and 70% of the inactive one. The corresponding
fragment nodes are set to 0.
To construct our belief network classiﬁer, we needed to
estimate the strength of the relationships represented by the
network by encoding a set of conditional probability
distributions. Speciﬁcally, for any nonroot node A in the
network, where A has a set of parent nodes {P1, P2, ..., Pn}, we
must estimate the probability P(A|P1, P2, ..., Pn), i.e., we need to
specify the conditional probability for the nonroot nodes and
P(t|f). We adapted the probabilities to the speciﬁcity of
chemical data. Our weighting scheme is derived of the InQuery
system and has been used successfully in our previous studies.
Here, it is proposed to use the following probabilities P(c|f) for
each fragment in a class c or molecule t vector.
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where
− α is a constant (which was set to 0.4 in our preliminary
experiments) that avoids the probabilities being equal to
0 for fragments not observed in the data set which is only
a sample of the existing compounds.
− av(nbf(c)) and nbf(t) are, respectively, the average
number of occurrences of the fragment f within the
class c (see (1)) and the number of occurrences of the
fragment f within the molecule t (only one molecule).
− nbco( f, c) and nbco( f, c)̅ are the numbers of compounds
containing the fragment f within the class c or within the
other classes c ̅ representing the inactive training set.
− nbco(c) and nbco(c)̅ are the numbers of compounds in,
respectively, the class c and the other classes c.̅
The ratio between nbco( f, c) and nbco(c) is the fragment f
frequency among the class c. It modulates the weight of the
fragments by decreasing it when f is rare and increasing it when
f is ubiquitous within the class. At the same time, the ratio of
logs is near 1 when f is rare and near 0 when f is ubiquitous
outside the class c. This increases the probability of the
fragments that are speciﬁc of a class c.
Once the probabilities of each nodes of the network are
obtained, we calculate a similarity between the target t and each
of the classes by
∑
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The sum concerns the n fragments between the class node and
the target node and nb( f, c) and nb( f, t) are the numbers of
single fragments in the tested class c and the molecule t,
respectively.
Here, nb( f, c) ∩ nb( f, t) is the set of fragments in common
between the tested class and the molecule. If nbco( f, c)̅ is equal
to zero (meaning that this fragment never occurs in an inactive
training set), then the nbco( f, c)̅ in eq 4 is substituted with a
Figure 1. Bayesian belief network classiﬁer model.
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very small value given by 1/(nbco(c) + nbco(c)̅). However, it
should be noted that the calculation was carried out only for
nodes representing common fragments between the molecule
and the tested class. Once the similarity calculations against
each class are completed, the target molecule is assigned to the
most similar class.
BBNC is designed for classiﬁcation while BIN and BBN was
used for similarity searching. The main diﬀerence between
those methods is the nature of the network. In BBNC, the
leaves are, on one hand, the classes composed of numerous
compounds extracted from the training data sets and, on the
other end, the target compound; whereas in BBN each leaf
represents one compound of the data set and the target. So, in
BBNC the number of leaves corresponds to the number of
biological activity classes (generally less than hundred);
whereas, in BIN and BBN the number of leaves equals the
total number of compounds in the data set (generally several
thousands or more). Another diﬀerence is the calculation of the
belief of the fragments that is used for similarity searching in
BIN and BBN and for classiﬁcation in BBNC.
Machine Learning Algorithms. We have compared our
method to three machine learning algorithms available in
WEKA-Workbench:39 The naive Bayesian classiﬁer (NaiveB),40
the support vector machine classiﬁer, called LibSVM
(LSVM),41 and the neural network classiﬁer (RBFN).42 Details
of these algorithms can be found in their references. Finding
the optimal parameters for a classiﬁer is somewhat a tedious
process. However, WEKA-Workbench oﬀers the possibility of
automatically ﬁnding the best possible setup for LSVM
classiﬁer. Here, LSVM was used with linear kernel and the
following values: 0.1, 1.0, and 0.001 were assigned to the
Gamma, Cost, and Epsilon parameters, respectively. We used
supervised discretization to convert numeric attributes to
nominal ones in NaiveB classiﬁer and the minimum standard
deviation parameter was set to 0.01 in RBFN classiﬁer. The
remaining parameters were left as they are in default setup for
each classiﬁer in WEKA-Workbench.
Validation. Ten-fold cross-validation was used to validate
the results of BBNC and the other machine learning algorithms.
In this cross-validation, the data set was split into 10 parts; 9
were used for training and the remaining 1 was used for testing.
This process was repeated 10 times, so all the compounds were
used in the test set once. Each activity class was tested against
all the others, grouped. As in the case of many prediction
methods, we used the area under the reciever operating
characteristic (ROC) curve (AUC) as quality criterion to
quantify the performance of classiﬁcation algorithms. AUC is
deﬁned as (sensitivity + speciﬁcity)/2. The sensitivity is deﬁned
by sens = tp/(tp + fn) and speciﬁcity is deﬁned by spec = tn/
(tn + fp), where tp, tn, fp, and fn are the number of true
positives, true negatives, false positives, and false negatives,
respectively. A ROC curve describes the trade-oﬀ between
sensitivity and speciﬁcity, where the sensitivity and speciﬁcity
are deﬁned as the eﬀectiveness of a model to identify positive
and negative labels, respectively. The area under the ROC curve
(AUC) is a measure of the model performance: the closer to 1,
the better the performance of the prediction. We also used an
accuracy (ac) measurement to quantify the performance of the
classiﬁcation models. Accuracy is the overall eﬀectiveness of a
model and is calculated as the sum of correct classiﬁcations
divided by the total number of classiﬁcations ac = (tp + tn)/(tp
+ tn + fp + fn).
■ RESULTS AND DISCUSSION
The main aim of this study was to introduce the Bayesian belief
network classiﬁer approach into ligand-based target ﬁshing or
activity prediction and then identify the prediction accuracy of
such an approach. To achieve this aim, the BBNC approach
was compared with three machine learning algorithms available
in WEKA-Workbench: NaiveB, LSVM, and RBFN, used with
optimal parameters.
Visual inspection of the AUC and accuracy in Tables 5−8
enabled comparing the performances of the four prediction
algorithms. However, a more quantitative approach is possible
using the Kendall W test of concordance.43 This test was
developed to quantify the level of agreement between multiple
sets ranking the same set of objects. Here, we used this
approach to rank the performance of the tested algorithms. In
the present context, the data sets in Table 5 and the activity
classes in Tables 6−8 were considered as judges and the AUC
Table 5. Sensitivity, Speciﬁcity, AUC, and Accuracy Rates for the Prediction Models for Diﬀerent Data Sets
BBNC Naıv̈eB RBFN LSVM
activity class Sens Spec AUC Acc Sens Spec AUC Acc Sens Spec AUC Acc Sens Spec AUC Acc
COX2 0.99 0.99 0.99 98.19 1.00 0.99 1.00 99.79 0.93 0.76 0.84 86.94 1.00 1.00 1.00 100.00
BZR 0.99 0.91 0.95 92.11 0.94 0.61 0.78 86.17 0.99 0.65 0.82 90.62 1.00 1.00 1.00 100.00
DHFR 1.00 0.98 0.99 94.00 0.99 1.00 0.99 99.47 0.86 0.80 0.84 83.86 1.00 1.00 1.00 100.00
ER 1.00 0.90 0.95 89.13 1.00 1.00 1.00 100.00 0.62 0.70 0.64 64.89 1.00 1.00 1.00 100.00
MUT 0.74 0.85 0.80 78.59 0.59 0.84 0.72 71.74 0.69 0.50 0.59 59.00 0.72 0.71 0.71 71.60
mean 0.94 0.93 0.93 90.40 0.90 0.89 0.90 91.43 0.82 0.68 0.75 77.06 0.94 0.94 0.94 94.32
Table 6. Sensitivity, Speciﬁcity, AUC, and Accuracy Rates for the Prediction Models with the Norine Data Set
BBNC Naıv̈eB RBFN LSVM
activity class Sens Spec AUC Sens Spec AUC Sens Spec AUC Sens Spec AUC
antibiotics 0.96 0.91 0.94 0.88 0.77 0.82 0.90 0.96 0.93 0.96 0.95 0.96
toxin 0.90 0.97 0.94 0.66 0.92 0.79 0.87 0.93 0.90 0.92 0.97 0.95
siderophore 0.99 0.99 0.99 0.94 0.99 0.97 0.96 0.99 0.98 0.99 1.00 0.99
antitumor 0.23 0.99 0.61 0.48 0.97 0.48 0.60 0.97 0.79 0.64 0.98 0.81
protease inhibitors 0.92 1.00 0.96 0.73 0.97 0.49 0.82 0.99 0.90 0.91 1.00 0.95
mean 0.80 0.97 0.89 0.74 0.92 0.71 0.83 0.97 0.90 0.88 0.98 0.93
accuracy 92.10 80.99 88.60 93.88
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and accuracy measurement of the various prediction algorithms
as objects. The outputs of the test are the value of the Kendall
coeﬃcient, ranging from 0 (no agreement between set of ranks)
to 1 (complete agreement), and the associated signiﬁcance
level, which indicates whether this value of the coeﬃcient could
have occurred by chance. If the value is signiﬁcant (we use
cutoﬀ values of 0.01 or 0.05), then it is possible to give an
overall ranking of the objects that have been ranked. The
results of the Kendall analysis are reported in Table 9 and give
the ranking for the various prediction algorithms.
We ﬁrst considered the results of the ﬁrst ﬁve data sets
(COX2, BZR, DHFR, ER, and MUT). The results reported in
Table 5 showed that the LSVM produces the highest sensitivity,
speciﬁcity, AUC, and accuracy values compared to the other
approaches, with BBNC and NaiveB also performing well.
Table 9 showed that the value of the Kendall coeﬃcient, 0.549,
was signiﬁcant at the 0.05 cutoﬀ value. So, we can conclude that
the overall ranking of the four methods is: LSVM > BBNC =
NaiveB > RBFN. Here, the results in Table 9 suggested that the
BBNC has the second best performance after LSVM.
The good performance for LSVM and BBNC approaches
was not restricted to the ﬁrst ﬁve data sets since they also
perform best for the Norine and MDDR1 data sets (Tables 6
and 7). The results in Table 6 showed that LSVM and BBNC
produced the best performance across the ﬁve activity classes in
the Norine data set. In only one instance (antitumor class), the
performance of BBNC was not satisfying (Sens = 0.23 and
AUC = 0.61). This ﬁnding was in accordance to our previous
study.32 This is because the peptides with antitumor activity are
biologically closed to antibiotic and toxin peptides and can even
harbor several of those activities. Table 9 showed that the value
of the Kendall coeﬃcient, 0.845, was signiﬁcant at the 0.01
level; we can conclude that the overall ranking of the diﬀerent
methods is: LSVM > BBNC > RBFN > NaiveB.
The best performance of BBNC was seen with MDDR1
(Table 7). Sensitivity, speciﬁcity, and AUC values in Table 7
showed that BBNC and LSVM produced the best performance
compared to other approaches. Table 9 showed that the value
of the Kendall coeﬃcient, 0.751, is signiﬁcant at the 0.01 level
Table 7. Sensitivity, Speciﬁcity, AUC, and Accuracy Rates for the Prediction Models with the MDDR1 Data Set
BBNC Naıv̈eB RBFN LSVM
activity index Sens Spec AUC Sens Spec AUC Sens Spec AUC Sens Spec AUC
07707 1.00 1.00 1.00 0.99 1.00 0.99 0.63 1.00 0.82 0.98 1.00 0.99
07708 1.00 1.00 1.00 0.97 1.00 0.99 0.51 1.00 0.75 0.98 1.00 0.99
31420 0.99 1.00 1.00 1.00 1.00 1.00 0.96 0.96 0.96 1.00 1.00 1.00
42710 0.95 1.00 0.98 0.94 1.00 0.97 0.43 1.00 0.72 0.99 1.00 1.00
64100 0.99 0.99 0.99 0.95 1.00 0.97 0.97 0.90 0.94 1.00 1.00 1.00
64200 0.97 1.00 0.99 0.87 0.99 0.93 0.43 1.00 0.71 0.93 1.00 0.96
64220 0.98 1.00 0.99 1.00 1.00 1.00 0.95 0.97 0.96 1.00 1.00 1.00
64300 1.00 1.00 1.00 1.00 0.99 1.00 0.44 1.00 0.72 0.98 1.00 0.99
65000 1.00 1.00 1.00 1.00 1.00 1.00 0.80 1.00 0.90 1.00 1.00 1.00
75755 0.99 1.00 1.00 0.99 1.00 1.00 0.76 1.00 0.88 1.00 1.00 1.00
mean 0.99 1.00 0.99 0.97 1.00 0.98 0.69 0.98 0.84 0.99 1.00 0.99
accuracy 99.10 97.88 86.84 99.43
Table 8. Sensitivity, Speciﬁcity, AUC, and Accuracy Rates for the Prediction Models with the MDDR2 Data Set
BBNC Naıv̈eB RBFN LSVM
activity index Sens Spec AUC Sens Spec AUC Sens Spec AUC Sens Spec AUC
09249 0.89 0.98 0.93 0.91 0.99 0.95 0.82 0.98 0.90 0.98 1.00 0.99
12455 0.69 0.98 0.83 0.88 0.97 0.92 0.66 0.98 0.82 0.96 0.99 0.98
12464 0.75 0.98 0.86 0.85 0.99 0.92 0.75 0.95 0.85 0.92 1.00 0.96
31281 0.91 1.00 0.96 0.94 1.00 0.97 0.53 1.00 0.76 0.98 1.00 0.99
43210 0.86 0.95 0.91 0.84 0.99 0.91 0.78 0.97 0.87 0.96 0.99 0.98
71522 0.94 0.87 0.90 0.82 0.99 0.91 0.75 0.97 0.86 0.94 1.00 0.97
75721 0.95 0.98 0.97 0.91 0.99 0.95 0.86 0.98 0.92 0.99 1.00 0.99
78331 0.71 0.97 0.84 0.81 0.96 0.89 0.79 0.93 0.86 0.84 0.99 0.91
78348 0.85 0.93 0.89 0.65 0.99 0.82 0.74 0.96 0.85 0.91 1.00 0.95
78351 0.68 0.98 0.83 0.82 0.94 0.88 0.59 0.96 0.78 0.94 0.98 0.96
mean 0.82 0.96 0.89 0.84 0.98 0.91 0.73 0.97 0.85 0.94 0.99 0.97
accuracy 80.40 83.99 71.23 94.37
Table 9. Rankings of Prediction Approaches Based on
Kendall W Test Resultsa
data set W P ranking
AUC (DS1−5) 0.549 <0.05 LSVM > BBNC = NaiveB >
RBFN
AUC (Norine) 0.845 <0.01 LSVM > BBNC > RBFN >
NaiveB
AUC (MDDR1) 0.751 <0.01 BBNC > LSVM > NaiveB >
RBFN
AUC (MDDR2) 0.825 <0.01 LSVM > NaiveB > BBNC >
RBFN
Accuracy (all Data
sets)
0.622 <0.05 LSVM > BBNC > NaiveB >
RBFN
aThe contents of the columns above show the diﬀerent performance
measure for data set type, the value of the Kendall coeﬃcient, the
associated signiﬁcance probability, and the ranking of the methods,
respectively. The methods are ranked in decreasing order of prediction
performance.
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of statistical signiﬁcance. Given that the result is signiﬁcant, we
can hence conclude that the overall ranking of the diﬀerent
methods is BBNC > LSVM > NaiveB > RBFN. This
outstanding performance could be due to the low diversity of
MDDR1 data set.
Returning to Table 5, BBNC and others showed lower
prediction results (∼72%) for MUT compared to the ﬁrst four
data sets (COX2, BZR, DHFR, and ER). However, that was
because the MUT data set involves the most heterogeneous
activity class of those data sets. The same results can be
observed for MDDR2 in Table 8. The results in Tables 8 and 9
showed that the BBNC ranked third after LSVM and NaiveB.
The MUT and MDDR2 results are of particular interest since
they involved the most heterogeneous activity classes in the
eight data sets used in this study (except for Norine data set)
and thus provided a stiﬀ test of the eﬀectiveness of a prediction
method.
Visual inspection of the results in Tables 5−9 showed that
BBNC provides an interesting and promising method for
activity prediction. Beside the good performance of BBNC
method, BBNC was also very fast in comparison to other
machine learning algorithms, since building of the BBNC
model only depends on statistical calculation from active and
inactive training data.
Results in Tables 5−9 clearly showed that the performance
of each method was diﬀerent from one data set to another and
even from one activity to another. Thus, it is important to stress
that no prediction method is better than the others and able to
deal with all the data sets. However, we believe that using
diﬀerent methods for target prediction can help a better
understanding of data. Thus, we introduce BBNC as a useful
addition to the computational chemist’s toolbox.
■ CONCLUSION
This paper has further investigated the use of Bayesian belief
network classiﬁer for ligand-based target or activity prediction.
We applied the BBNC method on eight well-known data sets
from the literature and compared its performance to three
machine learning algorithms. Experiments showed that BBNC
provides interesting prediction rates (from 79% accuracy for a
high diverse data set to 99% for low diverse data set) with short
time calculation for activity prediction. Experiments also
showed that BBNC is particularly eﬀective for homogeneous
data sets but performs less well with structurally heterogeneous
ones. However, it is important to stress that we believe that
using several approaches, whenever possible, for target
prediction can often give a broader understanding of the data
than using only one approach alone. Thus, we see BBNC being
a useful addition to the computational chemist’s toolbox.
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